Singapore markets open in 6 hours 13 minutes

Talaris Therapeutics, Inc. (TALS)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.4500+0.0100 (+0.69%)
At close: 04:00PM EST
1.4500 0.00 (0.00%)
After hours: 04:01PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 60.15M
Enterprise value -130.62M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)0.31
Enterprise value/revenue N/A
Enterprise value/EBITDA 1.89

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-89.32%
S&P500 52-week change 3-11.32%
52-week high 316.6300
52-week low 31.1600
50-day moving average 31.8808
200-day moving average 35.2123

Share statistics

Avg vol (3-month) 3205.8k
Avg vol (10-day) 382k
Shares outstanding 540.33M
Implied shares outstanding 6N/A
Float 812.99M
% held by insiders 115.43%
% held by institutions 174.11%
Shares short (14 Nov 2022) 4703.82k
Short ratio (14 Nov 2022) 41.7
Short % of float (14 Nov 2022) 42.91%
Short % of shares outstanding (14 Nov 2022) 41.69%
Shares short (prior month 13 Oct 2022) 4565.29k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-18.98%
Return on equity (ttm)-30.90%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -69.82M
Net income avi to common (ttm)-69.61M
Diluted EPS (ttm)-1.5110
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)193.87M
Total cash per share (mrq)4.65
Total debt (mrq)3.1M
Total debt/equity (mrq)1.59
Current ratio (mrq)21.61
Book value per share (mrq)4.70

Cash flow statement

Operating cash flow (ttm)-56.82M
Levered free cash flow (ttm)-34.97M